Physician profile
Ryan Willis
NPI 1891441945
$824.57
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $514 · 2023: $270 · 2024: $40.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $304.69 | 2022-2023 | Urolift |
| Pfizer INC. | $271.58 | 2022-2023 | |
| Ambu INC. | $82.60 | 2023-2024 | |
| Progenics Pharmaceuticals, INC. | $48.72 | 2022-2023 | Pylarify |
| Myovant Sciences INC. | $35.82 | 2022 | |
| Urogen Pharma, INC. | $19.10 | 2023 | Jelmyto |
| Accord Healthcare, INC. | $17.28 | 2022 | |
| Sumitomo Pharma America, INC. | $15.30 | 2023 | Orgovyx |
| Tolmar, INC. | $15.19 | 2023 | |
| Astellas Pharma US INC | $14.29 | 2023 | Myrbetriq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.